HOME >> MEDICINE >> NEWS
Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes

Journalists: See also the Roche International Award for Obesity Journalism

Roche announced today that the results of the 4 year landmark XENDOS study involving 3304 patients demonstrated that the weight loss medication Xenical can prevent or delay the development of type 2 diabetes. Furthermore, the XENDOS study data showed significant and sustained weight loss over the long term1.

Commenting on the results presented at the 9th International Congress on Obesity (ICO) in Sao Paulo, Brazil, Professor Lars Sjstrm the XENDOS principal investigator, said "Against the background of several studies which show lifestyle intervention in the prevention of diabetes to be successful, it is a significant step forward to be able to show that treatment with Xenical in combination with lifestyle modification is more effective than lifestyle intervention alone both in diabetes prevention and weight loss."

"The outstanding XENDOS study results show that Xenical has a key role in combating the diabetes epidemic. Diabetes is a dangerous and expensive complication to obesity - an effective and safe drug that helps to prevent or delay the disease, as well as to maintain weight loss over the long term, is of real value for millions of overweight people at risk of developing diabetes" said William M. Burns, head of the pharmaceutical division at Roche.

XENDOS study results showed that:

Xenical plus lifestyle intervention is significantly better than lifestyle intervention alone in preventing or delaying the development of type 2 diabetes

The risk of developing type 2 diabetes was 37% lower in people treated with Xenical plus lifestyle intervention compared with lifestyle intervention alone

Weight loss, both in the short and the long term, was significantly greater with Xenical plus lifestyle intervention compared with lifestyle intervention alone (-11.4 vs -
'"/>

Contact: Antonia Betts
antonia.betts@sh-international.com
917-295-2335
Shire Health International
26-Aug-2002


Page: 1 2 3

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark study demonstrates potential for nerve regeneration treatment of stroke
5. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
6. Landmark study uncovers reasons behind recurring back injury
7. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... Colo. (PRWEB) , ... August 14, 2019 , ... Inc. ... #2008 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s ... #41 among Colorado based companies and #153 in the Health sector. The list represents ...
(Date:8/14/2019)... PASADENA, Calif. (PRWEB) , ... August 13, 2019 ... ... Pasadena, California has joined the esteemed Haute Beauty network. , The Haute Beauty ... privileged to present Dr. Reyes-Bergano as a leading aesthetic medicine expert and our ...
(Date:8/14/2019)... ... August 14, 2019 , ... Today, consumers are taking a harder look ... their physical body, emotions and energy levels. The trick is finding food and beverages ... , That’s why founder Chris Harper created Chase – a delicious, guilt ...
(Date:8/12/2019)... ... August 12, 2019 , ... ... the $56,595,000 Series 2019A&B Bonds for Lesley University, which is currently rated A-/Stable ... 2019 Bonds will be used primarily to refund the outstanding debt on the ...
(Date:8/9/2019)... , ... August 09, 2019 , ... ... the continuation of its global expansion into Europe’s third largest pharmaceutical market with ... , Advanced Clinical’s entrance into Italy now completes the organization’s thorough coverage of ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... ... GA, 30501, is a comprehensive family dental practice that serves the Gainesville community ... cosmetic dentistry , endodontics and restorative dental care. The well-established practice is ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... 2005, announced it has successfully completed enrollment of 690 patients for a phase ... dose ranging, multicenter, randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of ...
(Date:8/15/2019)... ... August 15, 2019 , ... Donor ... for intended parents who are looking for egg donors, gestational surrogates and sperm ... looking for the ultimate concierge service and hands-on help in creating their families ...
Breaking Medicine Technology:
Cached News: